SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-103307
Filing Date
2013-03-12
Accepted
2013-03-12 16:56:54
Documents
24
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d459781d10k.htm 10-K 1274965
2 EX-4.1 d459781dex41.htm EX-4.1 9808
3 EX-10.6 d459781dex106.htm EX-10.6 8734
4 EX-10.18 d459781dex1018.htm EX-10.18 45035
5 EX-10.39 d459781dex1039.htm EX-10.39 62866
6 EX-10.40 d459781dex1040.htm EX-10.40 8627
7 EX-10.43 d459781dex1043.htm EX-10.43 161718
8 EX-23.1 d459781dex231.htm EX-23.1 1841
9 EX-31.1 d459781dex311.htm EX-31.1 9113
10 EX-31.2 d459781dex312.htm EX-31.2 9021
11 EX-32.1 d459781dex321.htm EX-32.1 3450
18 GRAPHIC g4597812.jpg GRAPHIC 210487
19 GRAPHIC g4597813.jpg GRAPHIC 141439
20 GRAPHIC g459781figure-1.jpg GRAPHIC 78539
21 GRAPHIC g459781figure-2.jpg GRAPHIC 53067
22 GRAPHIC g459781neu-vax.jpg GRAPHIC 48212
23 GRAPHIC g459781our-oncology1.jpg GRAPHIC 67554
24 GRAPHIC g459781our-oncology2.jpg GRAPHIC 59577
  Complete submission text file 0001193125-13-103307.txt   10541422

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT gale-20121231.xml EX-101.INS 1415317
13 XBRL TAXONOMY EXTENSION SCHEMA gale-20121231.xsd EX-101.SCH 117846
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gale-20121231_cal.xml EX-101.CAL 99191
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gale-20121231_def.xml EX-101.DEF 458004
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE gale-20121231_lab.xml EX-101.LAB 722990
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gale-20121231_pre.xml EX-101.PRE 544079
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 13684849
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences